By G HossainPosted on September 11, 2026Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs Back-to-back failures of multiple late-phase trials have raised questions about how Novartis has deployed capital in pursuit of drugs to drive growth through the 2030s. Novartis’ board faces investor scrutiny after M&A misfires and R&D flops Post navigation In age of AI, partners focus on relationships vs. productivityNovartis drags peers down with triple asset stumble